![](/img/cover-not-exists.png)
P3.03-019 Activity of PARP Inhibitor in NSCLC with Germline and Somatic Mutation and in Silico Chemotherapy Lethality
Barreto, C., Aguiar, P., Silverio, F., Yaksic, M., Manfrivato, M.F., Naraki, L., Souza, E., Tamura, P., Kobayashi, K., Zapata, L., Padua, T., Silva, F., Spada, M., Parmigiani, R., Yamaguchi, N.Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.1646
Date:
November, 2017
File:
PDF, 177 KB
english, 2017